United States Gemcitabine Market Report 2016

December 2016 | 98 pages | ID: UD96EBF1F84EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Gemcitabine

Revenue, means the sales value of Gemcitabine

This report studies sales (consumption) of Gemcitabine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Allergan
• Sanofi
• Pfizer
• The Medicines Company
• Theravance Biopharma
• Basilea Pharmaceutica

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Gemcitabine in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Gemcitabine Market Report 2016

1 GEMCITABINE OVERVIEW

1.1 Product Overview and Scope of Gemcitabine
1.2 Classification of Gemcitabine
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Gemcitabine
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Gemcitabine (2011-2021)
  1.4.1 United States Gemcitabine Sales and Growth Rate (2011-2021)
  1.4.2 United States Gemcitabine Revenue and Growth Rate (2011-2021)

2 UNITED STATES GEMCITABINE COMPETITION BY MANUFACTURERS

2.1 United States Gemcitabine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Gemcitabine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Gemcitabine Average Price by Manufactures (2015 and 2016)
2.4 Gemcitabine Market Competitive Situation and Trends
  2.4.1 Gemcitabine Market Concentration Rate
  2.4.2 Gemcitabine Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES GEMCITABINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Gemcitabine Sales and Market Share by Type (2011-2016)
3.2 United States Gemcitabine Revenue and Market Share by Type (2011-2016)
3.3 United States Gemcitabine Price by Type (2011-2016)
3.4 United States Gemcitabine Sales Growth Rate by Type (2011-2016)

4 UNITED STATES GEMCITABINE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Gemcitabine Sales and Market Share by Application (2011-2016)
4.2 United States Gemcitabine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES GEMCITABINE MANUFACTURERS PROFILES/ANALYSIS

5.1 Allergan
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Gemcitabine Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Allergan Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Sanofi
  5.2.2 Gemcitabine Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Sanofi Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Pfizer
  5.3.2 Gemcitabine Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Pfizer Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 The Medicines Company
  5.4.2 Gemcitabine Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 The Medicines Company Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Theravance Biopharma
  5.5.2 Gemcitabine Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Theravance Biopharma Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Basilea Pharmaceutica
  5.6.2 Gemcitabine Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Basilea Pharmaceutica Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview

6 GEMCITABINE MANUFACTURING COST ANALYSIS

6.1 Gemcitabine Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Gemcitabine

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Gemcitabine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Gemcitabine Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES GEMCITABINE MARKET FORECAST (2016-2021)

10.1 United States Gemcitabine Sales, Revenue Forecast (2016-2021)
10.2 United States Gemcitabine Sales Forecast by Type (2016-2021)
10.3 United States Gemcitabine Sales Forecast by Application (2016-2021)
10.4 Gemcitabine Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Gemcitabine
Table Classification of Gemcitabine
Figure United States Sales Market Share of Gemcitabine by Type in 2015
Table Application of Gemcitabine
Figure United States Sales Market Share of Gemcitabine by Application in 2015
Figure United States Gemcitabine Sales and Growth Rate (2011-2021)
Figure United States Gemcitabine Revenue and Growth Rate (2011-2021)
Table United States Gemcitabine Sales of Key Manufacturers (2015 and 2016)
Table United States Gemcitabine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Gemcitabine Sales Share by Manufacturers
Figure 2016 Gemcitabine Sales Share by Manufacturers
Table United States Gemcitabine Revenue by Manufacturers (2015 and 2016)
Table United States Gemcitabine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Gemcitabine Revenue Share by Manufacturers
Table 2016 United States Gemcitabine Revenue Share by Manufacturers
Table United States Market Gemcitabine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Gemcitabine Average Price of Key Manufacturers in 2015
Figure Gemcitabine Market Share of Top 3 Manufacturers
Figure Gemcitabine Market Share of Top 5 Manufacturers
Table United States Gemcitabine Sales by Type (2011-2016)
Table United States Gemcitabine Sales Share by Type (2011-2016)
Figure United States Gemcitabine Sales Market Share by Type in 2015
Table United States Gemcitabine Revenue and Market Share by Type (2011-2016)
Table United States Gemcitabine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Gemcitabine by Type (2011-2016)
Table United States Gemcitabine Price by Type (2011-2016)
Figure United States Gemcitabine Sales Growth Rate by Type (2011-2016)
Table United States Gemcitabine Sales by Application (2011-2016)
Table United States Gemcitabine Sales Market Share by Application (2011-2016)
Figure United States Gemcitabine Sales Market Share by Application in 2015
Table United States Gemcitabine Sales Growth Rate by Application (2011-2016)
Figure United States Gemcitabine Sales Growth Rate by Application (2011-2016)
Table Allergan Basic Information List
Table Allergan Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan Gemcitabine Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Gemcitabine Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Gemcitabine Sales Market Share (2011-2016)
Table The Medicines Company Basic Information List
Table The Medicines Company Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Table The Medicines Company Gemcitabine Sales Market Share (2011-2016)
Table Theravance Biopharma Basic Information List
Table Theravance Biopharma Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Theravance Biopharma Gemcitabine Sales Market Share (2011-2016)
Table Basilea Pharmaceutica Basic Information List
Table Basilea Pharmaceutica Gemcitabine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Basilea Pharmaceutica Gemcitabine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gemcitabine
Figure Manufacturing Process Analysis of Gemcitabine
Figure Gemcitabine Industrial Chain Analysis
Table Raw Materials Sources of Gemcitabine Major Manufacturers in 2015
Table Major Buyers of Gemcitabine
Table Distributors/Traders List
Figure United States Gemcitabine Production and Growth Rate Forecast (2016-2021)
Figure United States Gemcitabine Revenue and Growth Rate Forecast (2016-2021)
Table United States Gemcitabine Production Forecast by Type (2016-2021)
Table United States Gemcitabine Consumption Forecast by Application (2016-2021)